CC_586764/2023

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Verletzungs-Hauptverfahren:UPC_CFI_14/2023

NichtigkeitWiderklage auf NichtigkeitMunich CDCounter claim for revocationCase Closed

Dieser Fall zitiert

In den Entscheidungen dieses Falls zitierte Quellen.

Quelle	Rechtsfrage	Bindungskraft	Auszug
87	priority	Bindend	A claimed invention is to be considered the same invention as meant in Article 87 EPC (priority right) if the skilled person can derive the subject-matter of the claim directly and unambiguously from the previous application as a whole
56	inventive step	Bindend	the Patent is revoked entirely, on the ground of Article 138 (1) sub a in connection with Article 56 EPC (Article 65(2) UPCA)
138	inventive step	Bindend	the Patent is revoked entirely, on the ground of Article 138 (1) sub a in connection with Article 56 EPC (Article 65(2) UPCA)
65	inventive step	Bindend	Article 138 (1) sub a in connection with Article 56 EPC (Article 65(2) UPCA)
76	inventive step	Bindend	taking into account Article 76 UPCA, according to which a decision on the merits may only be based on grounds, facts and evidence, which were submitted by the parties
69	security for costs	Bindend	In accordance with Article 69 UPCA and Rule 118.5 RoP the Defendant, as the unsuccessful party, has to bear the legal costs of the Claimant

Quelle	Rechtsfrage	Bindungskraft	Auszug
118.5	security for costs	Bindend	In accordance with Article 69 UPCA and Rule 118.5 RoP the Defendant, as the unsuccessful party, has to bear the legal costs of the Claimant

Quelle	Rechtsfrage	Bindungskraft	Auszug
AC Decision on the Scale of Ceilings for Recoverable Costs dated 23 April 2023, D - AC/10/24042023_E	security for costs	Bindend	see AC Decision on the Scale of Ceilings for Recoverable Costs dated 23 April 2023, D - AC/10/24042023_E

Zitiert in

Spätere UPC-Entscheidungen, die diesen Fall zitieren.

Bisher in keiner anderen Entscheidung unseres Korpus zitiert.